Skip to main content

ATLAS CAPITAL ADVISORS INC.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1434165 JACKSON, WY

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$63,371
+$61,659 QoQ
Shares Held
376
+2792.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#632
of 768 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ATLAS CAPITAL ADVISORS INC. holds $1,827,271 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
376 $63,371

All Filings in NBIX

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $63,371 376
2026-03-31 $1,712 13
2025-12-31 $1,843 13